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Background: Prophylactic ventricular tachycardia substrate
ablation (PVTSA) reduces the rate of appropriate therapies in
secondary prevention ICD patients. Scar characteristics assessed
by contrast-enhanced magnetic resonance (ceMRI) predict VT
recurrences after ICD implantation.
Objectives: The aim of this study was to determine the
capability of ceMRI based signal intensity (SI) mapping to predict
appropriate ICD therapies after PVTSA.
Methods: Twenty-six consecutive patients with previous
myocardial infarction (Age: 68±9 years, LVEF: 32±9%) and
secondary prevention indication for ICD implantation were
included. Prior to PVTSA and ICD, a ceMRI was obtained and the
averaged subendocardial and subepicardial SI was projected
onto 3D endocardial and epicardial shells in which dense scar,
heterogeneous tissue (HT) and normal tissue were differentiated
based on SI (Scar: SI>2SD above SI in normal tissue; Dense scar:
SI> 3SD; HT: 2SD<SI<3SD) and measured.
Results: During a mean follow-up of 40± 23 months, 17
patients were free of appropriate therapies (65%) and 9 (35% )
presented at least with 1 appropriate therapy. No differences
were observed in LV end diastolic volume (221±87 vs. 262±52
cc, p:.2), LV end systolic volume (153±83 vs. 183±41 cc, p:.3),
LVEF (33±10 vs. 32±7, p: ns) and infarct mass ( 40±40 vs. 48±30
grams, p: ns.). The table shows SI mapping differences. The
figure shows survival curves when the endocardial total scar was
dichotomized above and below the median value.
Conclusion: ceMRI based SI mapping identifies the group of
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patients with a better outcome after ablation. This information
could help select the patients for PVTSA prior to ICD
implantation.
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